ERBB2 and breast ductal adenocarcinoma: Multivariable Analysis of All-Cause Mortality Among Patients With Strongly Hormone Receptor–Positive and Human Epidermal Growth Factor Receptor 2–Negative Invasive Ductal Carcinoma Receiving Neoadjuvant Treatments